| Description |
1 online resource (x, 292 pages) : illustrations |
| Series |
Current clinical oncology |
|
Current clinical oncology (Totowa, N.J.)
|
| Contents |
Molecular biology of colon cancer / William M. Grady -- Chemoprevention of colorectal cancer / Yu-Ning Wong [and others] -- Colorectal cancer screening and surveillance / Arnold J. Markowitz -- Cytotoxic chemotherapy for metastatic colorectal cancer / M. Wasif Saif, Richard Kim, and Edward Chu -- Integration of antiangiogenic strategies in colorectal cancer treatment / John M. Strother and Charles D. Blanke -- The role of EGFR inhibition in colorectal cancer / Nabeel Shalan and Paulo M. Hoff -- Second-line strategies in the treatment of patients with metastatic colorectal cancer / Anthony B. El-Khoueiry and Heinz-Josef Lenz -- Adjuvant chemotherapy for colon cancer / Bert H. O'Neil [and others] -- Management of locally advanced rectal cancer / Yu Jo Chua and David Cunningham -- Rationale for adjuvant and neoadjuvant chemotherapy in the resection of liver metastases / Axel Grothey and Steven A. Alberts -- Percutaneous radiofrequency ablation in the management of patients with colorectal cancer / Karen Brown -- Colorectal cancer imaging / Sean D. Curran and Laurence H. Schwartz -- Nursing issues in colorectal cancer chemotherapy / Ellen Hollywood and Deborah Semple -- Pain management in the colorectal cancer patient / Vivek Tim Malhotra -- Novel agents and new paradigms for colorectal cancer / Chris Takimoto and Russell Kruzelock |
| Summary |
Management options for patients with colorectal cancer have undergone d- matic changes over the past decade. Whereas at the start of 1996 only one drug, 5-Fluorouracil, was available for the treatment of this disease, a mere 10 yr later, six drugs are licensed for use in colorectal cancer, and others are in the late phases of clinical development. Likewise, surgical and ablative options, as well as an array of supportive medications, have shown substantial progress and undergone a dramatic proliferation over the past decade. With the increased number of therapeutic options from which to choose, the clinician is better able to offer effective therapy to the patient with colorectal cancer. The clinician is challenged, however, to keep up with the rapidly changing landscape and the rapidly emerging data that shape the options for treatment today and tom- row. In this text, leaders in the management of colorectal cancer review the current literature that has led us to where we are today. Critical evaluations of the data are offered, and evidence-based recommendations are made |
| Bibliography |
Includes bibliographical references and index |
| In |
Springer e-books |
| Subject |
Colon (Anatomy) -- Cancer -- Chemotherapy
|
|
Rectum -- Cancer -- Chemotherapy
|
|
Evidence-based medicine.
|
|
Colorectal Neoplasms -- drug therapy
|
|
Drug Therapy -- methods
|
|
Evidence-Based Medicine
|
|
MEDICAL -- Oncology.
|
|
HEALTH & FITNESS -- Diseases -- Cancer.
|
|
Evidence-Based Medicine.
|
|
Rectum -- Cancer -- Chemotherapy.
|
|
Colon (Anatomy) -- Cancer -- Chemotherapy.
|
|
Evidence-based medicine
|
|
Rectum -- Cancer -- Chemotherapy
|
| Form |
Electronic book
|
| Author |
Saltz, Leonard B.
|
| ISBN |
1588297519 |
|
9781588297518 |
|
9781588297518 |
|
9781597452151 |
|
1597452157 |
|
